Ovarian Cancer Trial, Recruiting NCT07676370 Sponsor: Hospital Vall d'Hebron Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07676370
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with ovarian cancer.
  • People who are having surgery to remove as much of the tumour as possible — this includes surgery done as the first step, surgery done partway through treatment, or surgery done after six rounds of chemotherapy.
  • People whose surgery is carried out through a single vertical cut down the middle of the abdomen.
  • People who are able and willing to sign a written consent form agreeing to take part.

Who may not be able to join:

  • People having surgery for ovarian cancer that has come back after previous treatment (second, third, or later surgeries for recurrence).
  • People whose surgery is planned using a minimally invasive approach (such as keyhole/laparoscopic surgery).
  • People who have another tumour-removal surgery already planned within the 24 months after joining the trial.
  • People who are not able or not willing to attend the required follow-up appointments and checks during the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34 932746000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Vall d'Hebron
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Incidence of Incisional Hernia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov